Pulmonx (LUNG) Gains from Investment Securities (2019 - 2025)
Pulmonx (LUNG) reported Gains from Investment Securities of -$122000.0 for Q3 2025, down 206.09% year-over-year from $115000.0 in Q3 2024, and down 1120.0% on a QoQ basis from -$10000.0 in Q2 2025.
Pulmonx (LUNG) has 7 years of Gains from Investment Securities data on file, last reported at -$122000.0 in Q3 2025.
- Quarterly Gains from Investment Securities fell 206.09% year-over-year to -$122000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $744000.0 (up 362.9% YoY) and the FY2024 annual result came in at $556000.0, up 1444.44% from the prior year.
- Gains from Investment Securities eased to -$122000.0 in Q3 2025 per LUNG's latest filing, from -$10000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $507000.0 in Q4 2024 and bottomed at -$332000.0 in Q4 2023.
- The 5-year median for Gains from Investment Securities is $5000.0 (2023), against an average of $63157.9.
- The widest annual swing landed in 2022, when Gains from Investment Securities jumped 11333.33%; it then slumped 620.0% in 2024.
- Tracing LUNG's Gains from Investment Securities over 5 years: stood at $290000.0 in 2021, then sank by 199.31% to -$288000.0 in 2022, then retreated by 15.28% to -$332000.0 in 2023, then jumped by 252.71% to $507000.0 in 2024, then plunged by 124.06% to -$122000.0 in 2025.
- Per Business Quant, the three latest LUNG Gains from Investment Securities figures stand at -$122000.0 (Q3 2025), -$10000.0 (Q2 2025), and $369000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -122,000.00 |
| Sep 30, 2025 | -122,000.00 |
| Jun 30, 2025 | -10,000.00 |
| Jun 30, 2025 | -10,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Dec 31, 2024 | 507,000.00 |
| Dec 31, 2024 | 507,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Jun 30, 2024 | -40,000.00 |
| Jun 30, 2024 | -40,000.00 |
| Mar 31, 2024 | -26,000.00 |
| Mar 31, 2024 | -26,000.00 |
| Dec 31, 2023 | -332,000.00 |
| Dec 31, 2023 | -332,000.00 |
| Sep 30, 2023 | 162,000.00 |
| Sep 30, 2023 | 162,000.00 |
| Jun 30, 2023 | 201,000.00 |
| Jun 30, 2023 | 201,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | -288,000.00 |
| Dec 31, 2022 | -288,000.00 |
| Sep 30, 2022 | 343,000.00 |
| Sep 30, 2022 | 343,000.00 |
| Jun 30, 2022 | -35,000.00 |
| Jun 30, 2022 | -35,000.00 |
| Mar 31, 2022 | 29,000.00 |
| Mar 31, 2022 | 29,000.00 |
| Dec 31, 2021 | 290,000.00 |
| Dec 31, 2021 | 290,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 37,000.00 |
| Jun 30, 2021 | 37,000.00 |
| Mar 31, 2021 | -8,000.00 |
| Mar 31, 2021 | -8,000.00 |
| Dec 31, 2020 | 330,000.00 |
| Dec 31, 2020 | 330,000.00 |
| Sep 30, 2020 | 113,000.00 |
| Sep 30, 2020 | 113,000.00 |
| Jun 30, 2020 | 45,000.00 |
| Jun 30, 2020 | 45,000.00 |
| Mar 31, 2020 | -229,000.00 |
| Mar 31, 2020 | -229,000.00 |
| Dec 31, 2019 | -12,000.00 |
| Dec 31, 2019 | -12,000.00 |